泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TTNP 泰坦制药

盘前交易 07-22 05:02:41 EDT

6.35

+0.13

+2.09%

最高6.35	最低6.05	成交量2,726
今开6.05	昨收6.22	日振幅4.82%
总市值580.54万	流通市值444.54万	总股本91.42万
成交额1.66万	换手率0.39%	流通股本70.01万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TTNP","market":"US","secType":"STK","nameCN":"泰坦制药","latestPrice":6.35,"timestamp":1721419200000,"preClose":6.22,"halted":0,"volume":2726,"delay":0,"floatShares":700056,"shares":914234,"eps":-6.371704,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.13,"latestTime":"07-22 05:02:41 EDT","open":6.0501,"high":6.35,"low":6.0501,"amount":16640.1593304,"amplitude":0.048215,"askPrice":6.91,"askSize":100,"bidPrice":3.01,"bidSize":51,"shortable":3,"etf":0,"ttmEps":-6.371704,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"adjPreClose":6.07,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":6.35,"preClose":6.35,"latestTime":"19:53 EDT","volume":9,"amount":55.08,"timestamp":1721433211826},"volumeRatio":0.15211713888424688,"impliedVol":2.3693,"impliedVolPercentile":0.4711},"requestUrl":"/m/hq/s/TTNP","defaultTab":"news","newsList":[{"id":"2452435987","title":"泰坦制药盘中异动 早盘快速拉升5.82%报6.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452435987","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452435987?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:10","pubTimestamp":1721315445,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时10分，泰坦制药股票出现异动，股价快速拉升5.82%。截至发稿，该股报6.00美元/股，成交量2456股，换手率0.27%，振幅3.19%。泰坦制药股票所在的生物技术行业中，整体跌幅为1.06%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182310469681e1b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182310469681e1b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2452165142","title":"泰坦制药盘中异动 早盘股价大涨5.58%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452165142","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452165142?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:49","pubTimestamp":1721227799,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时49分，泰坦制药股票出现异动，股价大幅上涨5.58%。截至发稿，该股报5.49美元/股，成交量2585股，换手率0.28%，振幅2.37%。泰坦制药股票所在的生物技术行业中，整体跌幅为1.69%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225000941f7efa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225000941f7efa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2452946823","title":"泰坦制药盘中异动 股价大涨7.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452946823","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452946823?lang=zh_cn&edition=full","pubTime":"2024-07-17 01:56","pubTimestamp":1721152606,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日01时56分，泰坦制药股票出现异动，股价大幅拉升7.92%。截至发稿，该股报5.04美元/股，成交量928股，换手率0.10%，振幅6.21%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.23%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170156469681d404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170156469681d404&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2450535940","title":"泰坦制药盘中异动 股价大跌6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535940","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450535940?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:40","pubTimestamp":1720791639,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时40分，泰坦制药股票出现异动，股价急速下挫6.12%。截至发稿，该股报4.60美元/股，成交量213股，换手率0.02%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.76%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214039941f6a98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712214039941f6a98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2450818188","title":"泰坦制药盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450818188","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450818188?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:35","pubTimestamp":1720618546,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时35分，泰坦制药股票出现波动，股价快速上涨5.02%。截至发稿，该股报5.13美元/股，成交量26股，换手率0.00%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.16%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213547af919c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213547af919c62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2450707288","title":"泰坦制药盘中异动 下午盘急速跳水6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450707288","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450707288?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:15","pubTimestamp":1720552501,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时15分，泰坦制药股票出现异动，股价大幅跳水6.41%。截至发稿，该股报4.82美元/股，成交量1910股，换手率0.21%，振幅6.41%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.82%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071003150195993ca4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071003150195993ca4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2446553236","title":"泰坦制药盘中异动 急速下跌7.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446553236","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446553236?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:41","pubTimestamp":1719495694,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时41分，泰坦制药股票出现波动，股价快速跳水7.60%。截至发稿，该股报5.66美元/股，成交量672股，换手率0.07%，振幅3.27%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.09%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214134af8f89e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627214134af8f89e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2446559394","title":"泰坦制药盘中异动 急速跳水6.05%报6.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446559394","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446559394?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:08","pubTimestamp":1719410899,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时08分，泰坦制药股票出现波动，股价大幅下跌6.05%。截至发稿，该股报6.13美元/股，成交量2073股，换手率0.23%，振幅2.68%。泰坦制药股票所在的生物技术行业中，整体跌幅为1.24%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220819aef6bfb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626220819aef6bfb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2445720740","title":"泰坦制药盘中异动 早盘快速上涨9.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445720740","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445720740?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235877,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分，泰坦制药股票出现异动，股价快速拉升9.55%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.89%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213117968163c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213117968163c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2444460632","title":"泰坦制药盘中异动 急速跳水5.16%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444460632","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444460632?lang=zh_cn&edition=full","pubTime":"2024-06-20 23:40","pubTimestamp":1718898029,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日23时40分，泰坦制药股票出现异动，股价大幅跳水5.16%。截至发稿，该股报6.62美元/股，成交量5563股，换手率0.61%，振幅3.87%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.12%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620234029af8e7768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620234029af8e7768&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2444019597","title":"泰坦制药盘中异动 早盘大幅跳水8.07%报6.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444019597","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444019597?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:50","pubTimestamp":1718635800,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时50分，泰坦制药股票出现异动，股价快速下挫8.07%。截至发稿，该股报6.38美元/股，成交量339股，换手率0.04%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.25%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617225000af8de501&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240617225000af8de501&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2443736336","title":"泰坦制药盘中异动 急速下跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443736336","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443736336?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:31","pubTimestamp":1718371888,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时31分，泰坦制药股票出现波动，股价快速跳水6.34%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.21%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421312895b0c093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061421312895b0c093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2442554460","title":"泰坦制药盘中异动 早盘快速跳水6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442554460","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442554460?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199143,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分，泰坦制药股票出现波动，股价快速下跌6.05%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.39%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221322395a8e78b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221322395a8e78b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2442021319","title":"泰坦制药盘中异动 快速上涨6.45%报6.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442021319","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442021319?lang=zh_cn&edition=full","pubTime":"2024-06-12 00:31","pubTimestamp":1718123502,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日00时31分，泰坦制药股票出现异动，股价大幅拉升6.45%。截至发稿，该股报6.94美元/股，成交量28股，换手率0.00%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体跌幅为0.65%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612003142941edc93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612003142941edc93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2442873999","title":"泰坦制药盘中异动 下午盘股价大跌5.35%报6.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442873999","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442873999?lang=zh_cn&edition=full","pubTime":"2024-06-11 03:29","pubTimestamp":1718047775,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日03时29分，泰坦制药股票出现波动，股价快速下跌5.35%。截至发稿，该股报6.52美元/股，成交量743股，换手率0.08%，振幅3.34%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.12%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611032935941ed748&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611032935941ed748&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0},{"id":"2440353132","title":"泰坦制药盘中异动 股价大涨7.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440353132","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440353132?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:31","pubTimestamp":1717507888,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时31分，泰坦制药股票出现异动，股价大幅拉升7.37%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.16%。泰坦制药公司简介：泰坦制药有限公司是一家处于开发阶段的公司，利用 ProNeura 长期、连续的给药技术开发专有疗法。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213128958d9204&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604213128958d9204&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TTNP","BK4007"],"gpt_icon":0},{"id":"2437914692","title":"泰坦制药盘中异动 早盘股价大涨5.13%报6.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437914692","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437914692?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:26","pubTimestamp":1716387967,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时26分，泰坦制药股票出现异动，股价急速拉升5.13%。截至发稿，该股报6.68美元/股，成交量41股，换手率0.00%，振幅0.00%。泰坦制药股票所在的生物技术行业中，整体涨幅为0.24%。ProNeura 技术有潜力用于开发治疗多种慢性疾病的产品，对于慢性疾病患者而言，保持全天候的、稳定持续的血液药物水平可能使他们受益并改善医疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522222608af89afba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522222608af89afba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TTNP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.titanpharm.com","stockEarnings":[{"period":"1week","weight":0.435},{"period":"1month","weight":-0.0903},{"period":"3month","weight":-0.1325},{"period":"6month","weight":0.0325},{"period":"1year","weight":-0.4227},{"period":"ytd","weight":-0.2303}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Titan Pharmaceuticals, Inc.于1992年2月根据特拉华州法律成立。该公司是一家制药公司，利用专有的长期给药平台ProNeura开发治疗方法，用于治疗特定的慢性疾病，稳态给药有可能带来疗效或安全益处。ProNeura由一种小型固体植入物组成，由乙烯-醋酸乙烯酯或EVA和一种药物混合而成。产生的产物是一种固体基质，其设计目的是在一个简短的门诊程序中进行皮下给药，并在治疗期结束时以类似的方式去除。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.012139},{"month":2,"riseRate":0.555556,"avgChangeRate":0.039371},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.022961},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.054959},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.079034},{"month":6,"riseRate":0.555556,"avgChangeRate":0.008509},{"month":7,"riseRate":0.222222,"avgChangeRate":0.097005},{"month":8,"riseRate":0.125,"avgChangeRate":-0.158189},{"month":9,"riseRate":0.25,"avgChangeRate":-0.195825},{"month":10,"riseRate":0.25,"avgChangeRate":-0.031661},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.065792},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.092274}],"exchange":"NASDAQ","name":"泰坦制药","nameEN":"Titan Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰坦制药,TTNP,泰坦制药股票,泰坦制药股票老虎,泰坦制药股票老虎国际,泰坦制药行情,泰坦制药股票行情,泰坦制药股价,泰坦制药股市,泰坦制药股票价格,泰坦制药股票交易,泰坦制药股票购买,泰坦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰坦制药(TTNP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰坦制药(TTNP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}